Clinical trial Recruiting at 1 site Interventional Ages 30 to 50

Effects of lumbar mobilization techniques on lower cross syndrome

Official title: Effects of Lumber Sustained Natural Apophyseal Glides on Lower Cross Syndrome

Run by Riphah International University · NCT06707805 · Data updated 2026-11-12

This study is testing if a specific back treatment can help people with lower cross syndrome feel less pain and move better.

Quick facts

Study typeInterventional
Ages30 Years to 50 Years
SexAll
Enrollment36 (estimated)
SponsorRiphah International University
Academic / other
Locations1 site (Kotli, Azad Kashmir)
StatusRecruiting
StartedMay 1, 2024
Main results expectedMarch 31, 2025
Study endsMarch 31, 2025
Registry record updatedFebruary 21, 2025
Trial IDNCT06707805 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 30 to 50 who experience low back pain and exhibit symptoms of lower cross syndrome.

Probably not a fit

Patients with contraindications to spinal manipulation or those with significant musculoskeletal pathologies affecting the lower back may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the impact of sustained natural apophyseal glides (SNAGs) on individuals suffering from lower cross syndrome, a condition characterized by specific muscle imbalances leading to lower back pain and hypomobility. The research aims to assess how these mobilization techniques can correct biomechanical changes, such as hyperlordotic curves and anterior pelvic tilting, which are common in this syndrome. By focusing on noninvasive interventions, the study seeks to enhance patient well-being and movement quality through personalized physical therapy approaches. Participants will undergo traditional physical therapy alongside SNAGs to evaluate improvements in pain and mobility.

Why it matters

Potential benefit: If successful, this approach could significantly alleviate pain and improve mobility for patients with lower cross syndrome.

How similar studies have gone: While the specific application of SNAGs for lower cross syndrome may be novel, similar mobilization techniques have shown promise in other studies addressing spinal pain and dysfunction.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 30 to 50 years.
* Both genders
* Patient came with the complain of low back pain.
* Participants had to present with pain and hypomobility due to lower cross syndrome
* Participants had to meet the criteria for lower cross syndrome indicating tight hip flexors and erector spinae along with weak abdominals and glutei muscles
* Participants with hyperlordotic curve due to lower cross syndrome
* Participants presenting with anterior pelvic tilting greater than angle \>7-10 degrees
* Willing to provide informed consent to participate in study

Exclusion Criteria:Participants contraindicated to spinal manipulation

* Musculoskeletal pathologies affecting the lower back, pelvis, hips, or lower extremities (e.g., herniated disc, lumbar radiculopathy, lumbar stenosis, hip labral tear).
* Participants who had undergone any lumber or pelvic surgery, as it will affect sacroiliac joint mechanics.
* Generalized inflammatory or infective connective tissue disorder
* Pregnancy

Where it's running

  • Orthopaedic hospital
    Kotli, Azad Kashmir, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.